ascopubs.org

A phase I study of 2-hydroxyoleic acid (2-OHOA), a novel sphingomyelin synthase activator in patients (pt) with advanced solid tumors (AST) including refractory high grade ...

Phase I pharmacokinetic and pharmacodynamic results of novel anti-neutropenic factor for the prevention and treatment of febrile neutropenia. This is an ASCO Meeting Abstract from the 2016 ASCO Annual ...
Nature

Multiple activities of sphingomyelin synthase 2 generate saturated fatty acid– and/or monounsaturated fatty acid–containing diacylglycerol

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
ascopubs.org

Pivotal role of sphingomyelin synthase (SGMS) expression and activity in glioma patient survival presents a potential therapeutic target.

Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does ...